[ad_1]
Professor Vytautas Kasiulevičius shared five good news on his Facebook account. According to him, according to the indicators, Lithuania has already overtaken the Baltic countries in a good way and is close to Germany and Denmark.
Here is the full teacher log:
“Five good news to talk about.
1) Lithuania ends its quarantine without a curfew, once again approaching the figures of Germany and Denmark, which have good control over the pandemic, and well ahead of Latvia and Estonia. Maybe we can avoid the last wave of this semester without moderation and maintaining moderation?
2) The experience of Israel, which has vaccinated most of its population, has shown, even if 90% Covid-19 cases are caused by a new strain of the British virus, vaccination still reduces the number of hospitalizations by 40% and deaths by 35%. There is no basis for complaining about unsafe vaccines. All vaccines used in Lithuania are safe and feverish after AstrosZeneca, Moderna or Pfizer, a vaccine teacher, is not a teacher in resuscitation.
Lithuania has too few teachers not to protect them. That is why teachers are in the priority queue. I hope teachers understand the importance of this vaccine as well. Yes, the efficacy of vaccines may vary slightly, especially against a South African strain, and some may not stop the spread of this strain, we may need a vaccine that has already been updated in early fall to vaccinate, but all vaccines they still protect against serious illness and death for many vaccinated people.
3) Results from regular UK antibody tests show that the number of people with antibodies to SARS-CoV-2 is increasing every month. That number has already exceeded 10% in the UK and reached 17% among young people. Official statistics show that the proportion of Covid-19 patients registered in Lithuania is higher than in the UK, which means that regular representative antibody tests in Lithuania are very likely to show a higher proportion of patients in the UK. United than in the United Kingdom.
4) A large cohort study shows that prophylactic administration of anticoagulants (low molecular weight heparins and others) to hospitalized Covid-19 patients reliably reduces mortality. We have been doing this at the Santara clinics since March 2020.
5) More and more new drugs are coming to the rescue. The recovery study helped pinpoint the case for tocilizumab. Every 25 patients treated in the hospital for tocilizumab will avoid death. Actually, it is a lot, although the medicine is really expensive.
[ad_2]
